Entegrion
PrivateLast Round
Series D
Jul 5, 2022
Total Funding Raised
$89.34M
Company Overview
Entegrion operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Series D round in July 2022.
Entegrion is a life sciences company that develops and manufactures diagnostic tools designed for the clinical diagnosis and management of hemostasis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Defense Tech, Biotech Equipment
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Entegrion Comparables
Compare Entegrion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perosphere Technologies Inc. | 82% | |
| Sienco, Inc. | 81% | |
| FloBio | 79% |
For institutional investors. Book with your work email.
Entegrion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 5, 2022 | ||||
| Grant | Jul 31, 2012 | ||||
| Grant | Oct 4, 2011 | ||||
| Grant | Aug 25, 2011 | ||||
| Early Funding | Mar 31, 2011 | ||||
Grant | Aug 6, 2009 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Entegrion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Office of Naval Research | Grant |
| U.S. Navy | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 108% MoM.
- Jan 7, 2026
Monthly visitors increased 155% MoM.
For institutional investors. Book with your work email.
Entegrion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Entegrion's valuation, stock price, and market status.
Is Entegrion a public or private company?
Entegrion is a private company.
What is the current stock price of Entegrion?
Entegrion is a private company, so its shares have no public market price. Caplight tracks Entegrion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Entegrion worth (valuation)?
Valuation information for Entegrion is not publicly available.
Can I buy Entegrion stock?
Entegrion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Entegrion's last funding round?
Entegrion's most recent funding round was Series D on July 5, 2022.
Who are the main investors in Entegrion?
Key investors in Entegrion include United States Department of Defense, Office of Naval Research, U.S. Navy.
Will Entegrion IPO soon?
No public IPO plans have been announced for Entegrion.
How can I track Entegrion secondary market activity?
Caplight tracks bids, offers, and trades in Entegrion's shares on secondary markets.